"This new milestone shows the FDA’s trust in our work, enabling broader adoption of imaging AI as an integral part of value-based care," says Zohar Elhanani, CEO of Zebra Medical Vision. "Zebra-Med’s population health solutions have already demonstrated great value in identifying patients at risk for major osteoporotic fractures. The company remains firmly committed to its robust product roadmap, which is designed to advance population health and preventative care. I believe that our expected collaboration with Nanox, and the implementation of our AI solutions with Nanox’s technology can help impact millions of lives globally, while significantly reducing cost of care."
About Zebra Medical Vision
Ad Statistics
Times Displayed: 22175
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Zebra Medical Vision’s medical imaging AI solutions empower healthcare systems and payers to identify patients at risk of having chronic disease, allowing them to fill treatment gaps and initiate new preventative care pathways. Zebra Medical’s solutions provide for more accurate risk-adjustment, timely intervention, and optimization of health system service quality and resources, while significantly reducing the associated costs. Analyzing millions of clinical images in real time, the Zebra AI-based solutions detect various medical indications alerting relevant healthcare stakeholders triggering new care pathways. Zebra Medical Vision’s solutions integrate into existing radiology workflows, including primary care physicians and specialists in cardiology, bone health and others.
Back to HCB News
